After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Research led by Brock University has found a possible cure ... Pulmonary fibrosis is one of many diseases triggered by isoDGR. Other conditions include chronic inflammation, cardiovascular disease ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... Sep. 26, 2024 — What factors lead to chronic respiratory disease? Researchers investigated this question using health data ...